Case report
Open access
Sep 2026
Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases
Frontline CAR-T-cell therapy combined with targeted agents may constitute a promising therapeutic paradigm for newly diagnosed SCNSL, yet these hypothesis-generating findings require validation in larger patient cohorts.
Qian-Ying Pan, Ran Zhao, Jing-Yi Yang et al.
· Frontiers in Oncology · 0 citations